Higher dose copaxone

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Higher dose copaxone

Postby bromley » Thu Jul 27, 2006 8:49 am

User avatar
Family Elder
Posts: 1888
Joined: Fri Sep 10, 2004 3:00 pm


Postby dignan » Thu Jul 27, 2006 11:00 am

I'm all in favor of doing large clinical trials -- really I am -- but why is it that suddenly all the crab makers seem to be doing REALLY big phase III trials of new formulations? I think you could do a satisfactory phase III trial with 500 participants. Drug companies complain about the expenses of trials, so wouldn't they prefer to have fewer participants? Are they trying to monopolize potential trial participants so they aren't available for competing trials?
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm

Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service